MedCity News June 26, 2023
Katie Adams

Eyenuk recently received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically detects diabetic retinopathy. The company said this FDA clearance makes its system the only AI system that is FDA-cleared for use with multiple retinal cameras produced by different manufacturers.

Last year, Eyenuk CEO Kaushal Solanki told MedCity News his company is on a mission to “screen every eye in the world” by leveraging its AI-powered disease detection technologies.

Eyenuk still has a lot of work to do to reach that goal, but the Los Angeles-based company did recently reach a significant milestone. It received FDA clearance to use the Topcon NW400 retinal camera with its EyeArt AI system, which automatically...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), FDA, Govt Agencies, Medical Devices, Technology
Related Articles:
Your Earphones And Headphones As Health And Medical Devices
Medtronic, Tempus testing AI to find potential TAVR patients
AI Robot Scanner as Good as Rheumatologists at Assessing RA
Regulatory Hurdles and Ethical Concerns Beset FDA Oversight of AI/ML Devices
From SpaceTech to MedTech: What medical device engineering teams can learn from aerospace

Share This Article